Free Trial

Evoke (LON:EVOK) Trading Up 17.2% - Here's Why

Evoke logo with Consumer Cyclical background

Evoke plc (LON:EVOK - Get Free Report) shares traded up 17.2% during mid-day trading on Wednesday . The company traded as high as GBX 45.90 ($0.60) and last traded at GBX 44.30 ($0.58). 3,500,189 shares traded hands during mid-day trading, an increase of 35% from the average session volume of 2,588,063 shares. The stock had previously closed at GBX 37.80 ($0.49).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reissued a "buy" rating and set a GBX 140 ($1.83) price objective on shares of Evoke in a report on Monday, December 16th.

Get Our Latest Report on Evoke

Evoke Stock Performance

The company's 50-day moving average is GBX 62.59 and its 200-day moving average is GBX 62.11. The firm has a market cap of £213.18 million, a price-to-earnings ratio of -1.19 and a beta of 0.84.

Evoke (LON:EVOK - Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, analysts predict that Evoke plc will post 12.7648305 EPS for the current year.

Insider Activity at Evoke

In other news, insider Jonathan (Jon) Mendelsohn bought 200,000 shares of the business's stock in a transaction on Monday, March 31st. The shares were bought at an average cost of GBX 48 ($0.63) per share, for a total transaction of £96,000 ($125,605.13). Also, insider Andrea Gisle Joosen bought 14,572 shares of the firm's stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 70 ($0.92) per share, with a total value of £10,200.40 ($13,346.07). 27.00% of the stock is currently owned by company insiders.

About Evoke

(Get Free Report)

Read More

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines